Current status of contemporary diagnostic radiotracers in the management of breast cancer: first steps toward theranostic applications

BACKGROUND: Expanding therapeutic possibilities have improved disease-related prospects for breast cancer patients. Pathological analysis on a tumor biopsy is the current reference standard biomarker used to select for treatment with targeted anticancer drugs. This method has, however, several limit...

Descripción completa

Detalles Bibliográficos
Autores principales: Altena, Renske, Tzortzakakis, Antonios, Af Burén, Siri, Tran, Thuy A., Frejd, Fredrik Y., Bergh, Jonas, Axelsson, Rimma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192501/
https://www.ncbi.nlm.nih.gov/pubmed/37195374
http://dx.doi.org/10.1186/s13550-023-00995-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192501/
https://www.ncbi.nlm.nih.gov/pubmed/37195374
http://dx.doi.org/10.1186/s13550-023-00995-2

Ejemplares similares